194 related articles for article (PubMed ID: 36410428)
1. Dysregulation of sphingosine-1-phosphate (S1P) and S1P receptor 1 signaling in the 5xFAD mouse model of Alzheimer's disease.
Jung Y; Lopez-Benitez J; Tognoni CM; Carreras I; Dedeoglu A
Brain Res; 2023 Jan; 1799():148171. PubMed ID: 36410428
[TBL] [Abstract][Full Text] [Related]
2. Sphk1/S1P/S1PR1 Signaling is Involved in the Development of Autoimmune Thyroiditis in Patients and NOD.H-2
Han C; He X; Xia X; Guo J; Liu A; Liu X; Wang X; Li C; Peng S; Zhao W; Zhou M; Shi X; Li Y; Li Y; Shan Z; Teng W
Thyroid; 2019 May; 29(5):700-713. PubMed ID: 30963819
[No Abstract] [Full Text] [Related]
3. Modulatory Effects of Fingolimod (FTY720) on the Expression of Sphingolipid Metabolism-Related Genes in an Animal Model of Alzheimer's Disease.
Jęśko H; Wencel PL; Lukiw WJ; Strosznajder RP
Mol Neurobiol; 2019 Jan; 56(1):174-185. PubMed ID: 29687345
[TBL] [Abstract][Full Text] [Related]
4. The S1P receptor 1 antagonist Ponesimod reduces TLR4-induced neuroinflammation and increases Aβ clearance in 5XFAD mice.
Zhu Z; Zhang L; Elsherbini A; Crivelli SM; Tripathi P; Harper C; Quadri Z; Spassieva SD; Bieberich E
EBioMedicine; 2023 Aug; 94():104713. PubMed ID: 37480622
[TBL] [Abstract][Full Text] [Related]
5. Beneficial Effects of Fingolimod in Alzheimer's Disease: Molecular Mechanisms and Therapeutic Potential.
Angelopoulou E; Piperi C
Neuromolecular Med; 2019 Sep; 21(3):227-238. PubMed ID: 31313064
[TBL] [Abstract][Full Text] [Related]
6. Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer's disease pathogenesis.
Couttas TA; Kain N; Daniels B; Lim XY; Shepherd C; Kril J; Pickford R; Li H; Garner B; Don AS
Acta Neuropathol Commun; 2014 Jan; 2():9. PubMed ID: 24456642
[TBL] [Abstract][Full Text] [Related]
7. Dual dose-dependent effects of fingolimod in a mouse model of Alzheimer's disease.
Carreras I; Aytan N; Choi JK; Tognoni CM; Kowall NW; Jenkins BG; Dedeoglu A
Sci Rep; 2019 Jul; 9(1):10972. PubMed ID: 31358793
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine-1-phosphate Attenuates Endoplasmic Reticulum Stress-induced Cardiomyocyte Apoptosis Through Sphingosine-1-phosphate Receptor 1.
Chen K; Wang Z; Liu C; Yang X; Jiang J
Arch Med Res; 2022 Sep; 53(6):562-573. PubMed ID: 35999060
[TBL] [Abstract][Full Text] [Related]
9. Microglial mTOR Activation Upregulates Trem2 and Enhances β-Amyloid Plaque Clearance in the
Shi Q; Chang C; Saliba A; Bhat MA
J Neurosci; 2022 Jul; 42(27):5294-5313. PubMed ID: 35672148
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine 1-phosphate enhances the excitability of rat sensory neurons through activation of sphingosine 1-phosphate receptors 1 and/or 3.
Li C; Li JN; Kays J; Guerrero M; Nicol GD
J Neuroinflammation; 2015 Apr; 12():70. PubMed ID: 25880547
[TBL] [Abstract][Full Text] [Related]
11. Sphingosine 1-phosphate signaling contributes to cardiac inflammation, dysfunction, and remodeling following myocardial infarction.
Zhang F; Xia Y; Yan W; Zhang H; Zhou F; Zhao S; Wang W; Zhu D; Xin C; Lee Y; Zhang L; He Y; Gao E; Tao L
Am J Physiol Heart Circ Physiol; 2016 Jan; 310(2):H250-61. PubMed ID: 26589326
[TBL] [Abstract][Full Text] [Related]
12. Targeting the SphK1/S1P/S1PR1 Axis That Links Obesity, Chronic Inflammation, and Breast Cancer Metastasis.
Nagahashi M; Yamada A; Katsuta E; Aoyagi T; Huang WC; Terracina KP; Hait NC; Allegood JC; Tsuchida J; Yuza K; Nakajima M; Abe M; Sakimura K; Milstien S; Wakai T; Spiegel S; Takabe K
Cancer Res; 2018 Apr; 78(7):1713-1725. PubMed ID: 29351902
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine 1-phosphate but not Fingolimod protects neurons against excitotoxic cell death by inducing neurotrophic gene expression in astrocytes.
Tran C; Heng B; Teo JD; Humphrey SJ; Qi Y; Couttas TA; Stefen H; Brettle M; Fath T; Guillemin GJ; Don AS
J Neurochem; 2020 Apr; 153(2):173-188. PubMed ID: 31742704
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine Kinase 2 Potentiates Amyloid Deposition but Protects against Hippocampal Volume Loss and Demyelination in a Mouse Model of Alzheimer's Disease.
Lei M; Teo JD; Song H; McEwen HP; Yup Lee J; Couttas TA; Duncan T; Chesworth R; Bertz J; Przybyla M; Van Eersel J; Heng B; Guillemin GJ; Ittner LM; Fath T; Garner B; Ittner A; Karl T; Don AS
J Neurosci; 2019 Nov; 39(48):9645-9659. PubMed ID: 31641049
[TBL] [Abstract][Full Text] [Related]
15. S1PR1 (Sphingosine-1-Phosphate Receptor 1) Signaling Regulates Blood Flow and Pressure.
Cantalupo A; Gargiulo A; Dautaj E; Liu C; Zhang Y; Hla T; Di Lorenzo A
Hypertension; 2017 Aug; 70(2):426-434. PubMed ID: 28607130
[TBL] [Abstract][Full Text] [Related]
16. Sphingosine-1-phosphate-lyase deficiency affects glucose metabolism in a way that abets oncogenesis.
Afsar SY; Alam S; Fernandez Gonzalez C; van Echten-Deckert G
Mol Oncol; 2022 Oct; 16(20):3642-3653. PubMed ID: 35973936
[TBL] [Abstract][Full Text] [Related]
17. A 50-Hz magnetic-field exposure promotes human amniotic cells proliferation via SphK-S1P-S1PR cascade mediated ERK signaling pathway.
Chen L; Xia Y; Lu J; Xie Q; Ye A; Sun W
Ecotoxicol Environ Saf; 2020 May; 194():110407. PubMed ID: 32146198
[TBL] [Abstract][Full Text] [Related]
18. Functional antagonism of sphingosine-1-phosphate receptor 1 prevents cuprizone-induced demyelination.
Kim S; Bielawski J; Yang H; Kong Y; Zhou B; Li J
Glia; 2018 Mar; 66(3):654-669. PubMed ID: 29193293
[TBL] [Abstract][Full Text] [Related]
19. Role of the S1P pathway and inhibition by fingolimod in preventing hemorrhagic transformation after stroke.
Salas-Perdomo A; Miró-Mur F; Gallizioli M; Brait VH; Justicia C; Meissner A; Urra X; Chamorro A; Planas AM
Sci Rep; 2019 Jun; 9(1):8309. PubMed ID: 31165772
[TBL] [Abstract][Full Text] [Related]
20. Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury.
Means CK; Xiao CY; Li Z; Zhang T; Omens JH; Ishii I; Chun J; Brown JH
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2944-51. PubMed ID: 17293497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
